AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitip-M 1 Tablet

Prescription Icon
Prescription Required

Marketer

Zodley Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimitip-M 1 Tablet

Metformin and Glimiperide combination tablets are used to manage type 2 diabetes in adults. This dual-action medication effectively regulates blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of complications like kidney disease, vision impairment, neuropathy, and limb loss. This medication is a component of a comprehensive diabetes management plan, including a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. To mitigate this risk, maintain regular mealtimes and carry a readily available fast-acting glucose source like sweets or juice. Alcohol consumption should be limited due to its potential to lower blood sugar. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before starting this treatment. Pregnant or breastfeeding individuals must consult their doctor. Regular blood glucose monitoring is essential, and your physician may order blood tests to monitor blood cell counts and liver function.

Uses of Glimitip-M 1 Tablet

Managing type 2 diabetes

Major Benefits of Glimitip-M 1 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. One Glimitip-M tablet should be taken with a meal.

Common Side effects of Glimitip-M 1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimitip-M 1 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimitip-M (1 tablet) should be administered with a meal.

How Glimitip-M 1 Tablet works:

Glimitip-M, a single tablet formulation, combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea derivative, enhances pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimitip-M 1 Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimitip-M 1 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimitip-M 1 Tablet are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimitip-M 1 Tablet cautiously, potentially requiring dosage modification. Physician consultation is essential. Glimitip-M 1 Tablet is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimitip-M 1 Tablet cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose of Glimitip-M 1 Tablet is typically prescribed for those with mild to moderate liver disease; its use is contraindicated in severe cases.

What if you forget to take Glimitip-M 1 Tablet :

Should you forget a Glimitip-M 1 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimitip-M 1 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimitip-M 1 Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glimitip-M 1 Tablet can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Glimitip-M 1 Tablet and seek immediate medical attention.
Glimitip-M 1 Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimitip-M 1 Tablet may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimitip-M 1 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Glimitip-M 1 Tablet can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimitip-M 1 Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimitip-M 1 Tablet
40
MRP 46
13% off